In our recent work to define a comprehensive genomic landscape of adenomas and at-risk mucosa, we found that patient-derived FAP adenomas do not just have the expected somatic APC mutations, but also recurrent mutations in Wnt pathway genes and in novel genes previously not linked to progressing colon adenomas to adenocarcinomas. Here, APC is linked to Familial adenomatous polyposis.